You can buy or sell Tilray and other stocks, options, and ETFs commission-free!
Tilray, Inc. engages in the research, cultivation, production, and distribution of medical cannabis and cannabinoids. The Company is focused on medical cannabis research, cultivation, processing and distribution of cannabis products worldwide.
Irwin David Simon
Nanaimo, British Columbia
52 Week High
52 Week Low
EXCLUSIVE: Tilray CEO Talks Symbios, Aphria, Market Opportunities On 'Power Hour'
Tilray Inc (NASDAQ:TLRY) recently announced the launch of Symbios, a medical cannabis brand the cannabis company said will provide a broader spectrum of formats
Why Is Tilray Trading Higher Today?
Tilray Inc (NASDAQ:TLRY) is trading higher Wednesday morning amid increased retail interest following the launch of a new medical cannabis brand. What Happened
— per share
Expected Aug 9, Pre-Market
The 'New' Tilray Launches Medical Cannabis Brand Symbios, Announces New Aphria Topicals
On Tuesday, Canadian cannabis company Tilray, Inc. (NASDAQ:TLRY) (TSX:TLRY) announced the launch of a new brand dubbed Symbios. This is the inaugural brand pro